BI 1703880
Phase 1- Indications
- Advanced solid tumors
Company intelligence / Profile preview
Valkyrie Clinical Trials
Los Angeles, California, USAvalkyrieclinicaltrials.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Phase 1
01
Overview
Valkyrie Clinical Trials is involved in various clinical trials for cancer and rare diseases, offering access to innovative treatments and contributing to advancements in gene therapy.
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Small moleculesGene therapyMonoclonal antibody
- Industry
- Contract Research Organization
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Pharmaceutical companiesresearchers
Beyond the preview
Go deeper on Valkyrie Clinical Trials.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Valkyrie Clinical Trials.